1. Academic Validation
  2. A Divergent Synthesis of Numerous Pyrroloiminoquinone Alkaloids Identifies Promising Antiprotozoal Agents

A Divergent Synthesis of Numerous Pyrroloiminoquinone Alkaloids Identifies Promising Antiprotozoal Agents

  • J Am Chem Soc. 2024 Oct 30;146(43):29883-29894. doi: 10.1021/jacs.4c11897.
Griffin L Barnes 1 Nicholas L Magann 1 Daniele Perrotta 1 Fabian M Hörmann 1 Sebastian Fernandez 1 Pratap Vydyam 2 Jae-Yeon Choi 2 Jacques Prudhomme 3 Armund Neal 3 Karine G Le Roch 3 Choukri Ben Mamoun 2 Christopher D Vanderwal 1 4
Affiliations

Affiliations

  • 1 Department of Chemistry, 1102 Natural Sciences II, University of California, Irvine, California 92697, United States.
  • 2 Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut 06520, United States.
  • 3 Department of Molecular, Cell and Systems Biology, University of California, Riverside, Riverside, California 92521, United States.
  • 4 Department of Pharmaceutical Sciences, University of California, 856 Health Sciences Road, Suite 5400, Irvine, California 92697, United States.
Abstract

On the basis of a streamlined route to the pyrroloiminoquinone (PIQ) core, we made 16 Natural Products spread across four classes of biosynthetically related alkaloid Natural Products, and multiple structural analogs, all in ≤8 steps longest linear sequence (LLS). The strategy features a Larock indole synthesis as the key operation in a five-step synthesis of a key methoxy-PIQ intermediate. Critically, this compound was readily diverged via selective methylation of either (or both) of the imine-like or pyrrole nitrogens, which then permitted further divergence by either O-demethylation to o-quinone Natural Products or displacement of the methoxy group with a range of amine nucleophiles. Based on a single, early report of their potential utility against the malaria Parasite, we assayed these compounds against several strains of Plasmodium falciparum, as well as two species of the related protozoan Parasite Babesia. In combination with evaluations of their human cytotoxicity, we identified several compounds with potent (low-nM IC50) antimalarial and antibabesial activities that are much less toxic toward mammalian cells and are therefore promising lead compounds for antiprotozoal drug discovery.

Figures
Products